Rubi, Spain

Jose-Antonio Cordero Rigol

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ipsen Pharma S.a.s.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose-Antonio Cordero Rigol. Retrieved from https://idiyas.com/inventor/jose-antonio-cordero-rigol

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jose-Antonio Cordero Rigol: Innovator in Pharmaceutical Compositions

Introduction

Jose-Antonio Cordero Rigol is a notable inventor based in Rubi, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of peptide analogues for medical applications. His work focuses on innovative solutions that aim to improve health outcomes for patients.

Latest Patents

Cordero Rigol holds a patent for GLP-1 pharmaceutical compositions. This invention is directed to peptide analogues of glucagon-like peptide-1 and their pharmaceutically acceptable salts. The patent outlines methods for using these analogues to treat mammals, as well as pharmaceutical compositions that incorporate these innovative compounds.

Career Highlights

Throughout his career, Cordero Rigol has been associated with Ipsen Pharma S.a.s., where he has contributed to various research and development projects. His expertise in pharmaceutical sciences has positioned him as a valuable asset in the industry.

Collaborations

Cordero Rigol has collaborated with notable colleagues, including Zheng Xin Dong and Roland Cherif-Cheikh. These partnerships have facilitated the advancement of his research and the successful development of innovative pharmaceutical solutions.

Conclusion

Jose-Antonio Cordero Rigol exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…